KATHY ORDONEZ

CIK 1222643 · Chief Commercial Officer · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.51M

Companies

4

Total Filings

55

Lifetime Open-Market Net

-$11.34M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PACB Director 403,037 $1.31 $528.0K -$10.87M 18 2026-06-04
QDEL Director 2,896 $14.13 $40.9K $0 5 2021-05-20
DGX SVP, Diagnostic Solutions 9,569 $203.06 $1.94M $0 9 2013-04-02
Celera CORP (CRA) Delisted CEO and Director 0 -$465.2K 22 2011-05-12

Recent Filings · Page 2 of 6

55 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-18 PACB Mixed −34,892 -$9.68M EDGAR
2020-08-06 PACB Grant (A) $0 EDGAR
2020-05-18 QDEL Exer (M) +1,856 $0 EDGAR
2020-05-14 QDEL Grant (A) $0 EDGAR
2019-06-24 QDEL Grant (A) $0 EDGAR
2019-02-20 PACB Mixed +13,017 -$49.7K EDGAR
2018-11-28 PACB Mixed -$116.0K EDGAR
2018-03-16 PACB Grant (A) +43,750 $0 EDGAR
2017-11-15 PACB Grant (A) $0 EDGAR
2017-05-25 PACB Grant (A) $0 EDGAR
Showing 1120 of 55
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.